MyPharmacy+

Vibifol Gold Syrup (Sugar Free)

Manufactured By Kivonyx Healthcare

Salt Synonyms

Rs. 103.55

MRP 109.00

(5% OFF)

Includes all taxes

Package SIZE

bottle of 200 ml Syrup

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Vibifol Gold Syrup (Sugar Free)

Uses / Indications:

As prescribed by the physician

Introduction:

Vibifol Gold Syrup (Sugar-Free) contains multivitamins and minerals to help maintain good blood pressure reducing the risk of heart disease. It also gives relief from pain

How to use:

It has anti-inflammatory properties|Multivitamins fill nutritional gaps and make sure people get their daily allowance of under-consumed nutrients|The combination of vitamins and minerals provides antioxidant support promotes a healthy prostate improves overall health and contributes to healthy bones|Methylcobalamin is helpful in people with pernicious anaemia|Pregabalin helps manage epilepsy and anxiety|It also deals with nerve pain

Description:

Deals with vitamin deficiency in the body|Contributes to healthy bones|It improves overall health

Benefits:

Safety Advise:

Read the label carefully before use|Store in a cool and dry place away from sunlight|Keep out of reach of children|Don’t exceed the recommended dosage

Vibifol Gold Syrup (Sugar Free)

Manufactured By Kivonyx Healthcare

Salt Synonyms

Rs. 103.55

MRP 109.00

Includes all taxes

Package SIZE

Available Substitutes

1-CC-FM Tablet

Azure Pharmaceuticals

1 Tree Milk Thistle Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Tree Sleep Right Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Vita Gold Tablet

Nextgen Healthcare

1 Vita Oral Drops

Nextgen Healthcare

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: